
Why organisations kill breakthrough projects, and how structure can protect them.
edition OL28720236M seen in search only.
Bahcall, a physicist who founded and ran a biotechnology company, argues that organisations kill breakthrough projects not because of bad culture but because of structure, and that the transition is a phase change of the kind physics describes. His central analogy is to water freezing, where a small change in temperature produces an abrupt change in behaviour, and he argues that organisations undergo the same kind of transition at a calculable size.
His mechanism is the competition between two incentives inside any organisation: the return to project work, which dominates in small teams, and the return to political rank-seeking, which dominates once the organisation is large enough that promotion outweighs project outcomes. He derives a rough formula for the transition point involving span of control, equity fraction, salary growth and management fit.
His prescription is separating what he calls artists and soldiers into distinct structures with equal status, protecting the loonshot group from the demands of the main business, and appointing what he calls a gardener who manages the transfer between them rather than choosing between them. He distinguishes P-type loonshots, which change the product, from S-type, which change the strategy or business model, and argues that organisations that survive one type frequently die of the other.
The historical cases include Vannevar Bush's wartime research organisation, Juan Trippe at Pan Am, Edwin Land at Polaroid, Akira Endo and statins, and the failures at Nokia and Pan Am. The physics framing is presented more as a source of intuition than as a demonstrated model, and the mathematics is illustrative rather than tested. The separation and gardener prescriptions are the transferable parts.
Executives at companies large enough that new projects keep dying, who want a structural rather than cultural explanation and specific separation mechanics.
Physicist; co-founder and former CEO of Synta Pharmaceuticals; previously a consultant at McKinsey & Company
One well-regarded book that reframes innovation as a phase transition, but a single title and a niche readership outside the innovation literature.
“This book explores the beauty, quirkiness, and complexity of ideas, especially new and out-of-the-box ones.”
Chosen by shared topics, the entries that hold them, and the people who recommended both.
Why businesses innovate best by deepening what they already do well.
Recommended by: Ev Williams, Keith Rabois
How a company can build new businesses through low-end and new-market disruption.
“Required reading for business-owners and investors. Shows how technology improves faster than people's ability to use it, so when someone says a technology is “not good enough”, add “yet” and prepare for disruption.” — Derek Sivers
Source: Derek Sivers book notes (primary, rated list) · Rating: 8/10
Recommended by: Derek Sivers, Keith Rabois and 3 others
Why imitating others' innovations matters as much as innovating.
Recommended by: Mohnish Pabrai
Why long-lived companies underperform the market, and how to transform them.
“Richard Foster and Sarah Kaplan, Creative Destruction (New York: Doubleday, 2001)” — Michael Mauboussin
Source: Innovation and Markets: How Innovation Affects the Investing Process, page 20
Recommended by: Michael Mauboussin, Mohnish Pabrai
How to anticipate change and create your own opportunities in business.
Recommended by: Tom Bilyeu
Strategies for firms that imitate other companies' innovations.
Recommended by: Mohnish Pabrai
As an Amazon Associate I earn from qualifying purchases.